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Pulsed xenon ultraviolet disinfection
Background: The role of contaminated environments in the spread of hospital-associated infections has
been well documented. This study reports the impact of a pulsed xenon ultraviolet no-touch disinfec-
tion system on infection rates in a community care facility.
Methods: This study was conducted in a community hospital in Southern Florida. Beginning November
2012, a pulsed xenon ultraviolet disinfection system was implemented as an adjunct to traditional clean-
ing methods on discharge of select rooms. The technology uses a xenon ﬂashlamp to generate germicidal
light that damages the DNA of organisms in the hospital environment. The device was implemented in
the intensive care unit (ICU), with a goal of using the pulsed xenon ultraviolet system for disinfecting all
discharges and transfers after standard cleaning and prior to occupation of the room by the next patient.
For all non-ICU discharges and transfers, the pulsed xenon ultraviolet system was only used for Clos-
tridium diﬃcile rooms. Infection data were collected for methicillin-resistant Staphylococcus aureus, C diﬃcile,
and vancomycin-resistant Enterococci (VRE). The intervention period was compared with baseline using
a 2-sample Wilcoxon rank-sum test.
Results: In non-ICU areas, a signiﬁcant reduction was found for C diﬃcile. There was a nonsigniﬁcant de-
crease in VRE and a signiﬁcant increase in methicillin-resistant S aureus. In the ICU, all infections were
reduced, but only VRE was signiﬁcant. This may be because of the increased role that environment plays
in the transmission of this pathogen. Overall, there were 36 fewer infections in the whole facility and 16
fewer infections in the ICU during the intervention period than would have been expected based on base-
line data.
Conclusion: Implementation of pulsed xenon ultraviolet disinfection is associated with signiﬁcant de-
creases in facility-wide and ICU infection rates. These outcomes suggest that enhanced environmental
disinfection plays a role in the risk mitigation of hospital-acquired infections.
© 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
BACKGROUND
The Centers for Disease Control and Prevention estimated a na-
tional burden of 722,000 hospital-acquired infections (HAIs)
occurring within acute care hospitals in 2011.1 This estimation is
house-wide, with over half of these infections occurring outside of
the intensive care unit (ICU). Approximately 4% of all patients that
are admitted will contract at least 1 HAI. Because >70% of gastro-
intestinal infections were caused by Clostridium diﬃcile, the Centers
for Disease Control and Prevention have recently changed their focus
to understanding the factors that may contribute to HAIs beyond
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actual operative procedures, with a particular emphasis given to un-
derstanding the role of contaminated surfaces within the patient
room.2,3
Substantial evidence exists that air and surfaces within the patient
room are regularly contaminated with multidrug-resistant organ-
isms (MDROs).4,5 Patients regularly shed organisms on skin squames
that have the potential to disperse over a wide range.6,7 Knelson et
al8 illustrated that both asymptomatic colonized patients and symp-
tomatic patients were equally as likely to contribute to this
environmental contamination with MDROs. Health care workers are
just as likely to contaminate their gloved hands when touching in-
animate surfaces aswhen touching the actual patient in amethicillin-
resistant Staphylococcus aureus (MRSA)–, vancomycin-resistant
Enterococci (VRE)–, or Clostridium diﬃcile–positive patient room.9-11
To make matters worse, the pathogens of common MDROs, partic-
ularly C diﬃcile spores, have the potential to survive for months on
dry surfaces if not adequately removed.12
Evidence supports what is known as prior room occupancy risk,
or the increased risk of acquiring an infection after being admit-
ted to a roomwith a previous MDRO-positive occupant rather than
one who did not have an MDRO.13 In fact, Shaughnessy et al14 de-
termined this prior room occupancy risk to be >2 times greater when
the previous patient had C diﬃcile. Because there is no physical
contact between patients, the effects of this comparison can be iso-
lated to that of environmental contamination.
Although interventions focusing on improved thoroughness and
adherence and manual cleaning protocols has decreased this en-
vironmental burden,15,16 there remains diﬃculty in sustaining
improved cleaning compliance. Carling et al17 demonstrated that only
47% of intended surfaces are actually contacted by a disinfectant
on a routine cleaning basis. Additionally, confusion in cleaning roles
between nursing and environmental surfaces can lead to inade-
quate disinfection of mobile medical devices used inmultiple patient
rooms.18
Pulsed xenon ultraviolet (PX-UV) disinfection is a non–user-
dependent technology that can be an additional adjunct to cleaning
regimens. Full-spectrum ultraviolet light has been found to improve
environmental cleanliness to a signiﬁcant degree, even eliminat-
ing MDROs, such as VRE, completely from selected high-touch
surfaces.19 Most importantly, hospitals that use PX-UV have actu-
ally signiﬁcantly mitigated infection risks associated with
environmentally mediated transmission routes, decreasing hospital-
acquired C diﬃcile and MRSA rates by 53% and 56%, respectively,
facility-wide.20,21
Although PX-UV can be of particular relevance within the ICU,
where patients have higher acuity and an increased utilization of
indwelling medical devices, these studies also suggest that this tech-
nology could be extended to acute care, non-ICU inpatient settings
where evidence based-literature is currently lacking.22 In this article
we describe the feasibility and impact of implementing a no-
touch PX-UV disinfection systemwithin the ICU and non-ICU setting
of an acute care hospital in an attempt to identify signiﬁcant changes
in the rates of hospital-acquired MDROs (particularly C diﬃcile).
METHODS
Facility and technology
South Seminole Hospital is a community hospital that is part of
Orlando Health, with 126 medical-surgical beds located in Central
Florida. The facility also houses an 80-bed psychiatric care unit. For
the duration of the study, infection data were collected and calcu-
lated using the National Healthcare Safety Network criteria.
Beginning in November 2012, a PX-UV disinfection system was
implemented as an adjunct to traditional cleaning methods on
discharge of select rooms. The technology uses a xenon ﬂashlamp
to generate full-spectrum germicidal light that damages the DNA
or RNA of pathogenic organisms. The full-spectrum, high-intensity
characteristics of PX-UV light emission allow for rapid disinfec-
tion of patient care areas.19
ICU implementation
In the ICU, the goal was for all room discharges and transfers to
be treated with no-touch disinfection after standard cleaning and
prior to the next patient occupying the room. Thismethodologywas
selected because there is evidence showing that rooms can become
contaminated with pathogenic organisms regardless of the infec-
tion or colonization status of the previous patient23; therefore,
implementation of a no-touch disinfection program should not be
limited to disinfection of rooms that previously housed only iso-
lation patients. The impact of colonized or infected patients will
extend beyond the room used for direct care because pathogenic
organismswill be transmitted toother roomsbycontaminatedmobile
medical equipment and on the hands of health care workers.24
Non-ICU implementation
For all non-ICU discharges and transfers, the no-touch disinfec-
tion systemwas only used for C diﬃcile discharges. This methodology
was selected because transmission of C diﬃcile was the most prev-
alent hospital-associated infection, and it was not feasible to disinfect
all discharges throughout the facility because of limitations on device
availability and proximity of location.
Pulsed xenon disinfection
PX-UV disinfection systems are used after the room has under-
gone standard terminal cleaning practices including the use of bleach
for C diﬃcle isolation rooms. To maximize the distribution of light
throughout a room, multiple positions are used when performing
no-touch disinfection. Based on previous studies, the following pro-
tocol was used: in a standard patient roomwith an integrated private
bathroom, the device is run for 1 cycle in the bathroom and 1 cycle
on both sides of the bed, for a total of 3 cycles, each lasting 5minutes.
If the room does not have a separate bathroom, only 2 cycles are
required.19 An onboard data log allows the hospital service team to
track which speciﬁc room is being disinfected at speciﬁc times and
notiﬁes the user when a disinfection cycle has been successfully
completed.
Statistical analysis
Infection rates (incidence divided by patient days) for the PX-
UV intervention were compared with infection rates before
implementation. Because the data were not normally distributed,
a 2-sample Wilcoxon rank-sum test indicated the signiﬁcance of
changes occurring (Stata Corp, College Station, TX).
RESULTS
PX-UV disinfection was implemented in >200 patient rooms per
month from November 2012-August 2014 (>4,400 rooms total) and
compared with January 2011-October 2012 (Table 1–3).
A signiﬁcant 29% facility-wide decrease in all 3 MDROs (C diﬃcile,
MRSA, and VRE) was determined (P = .01), statistically driven by a
41% decrease in C diﬃcile infection (P = .01). Although only mod-
erately signiﬁcant, the greatest decrease in facility-wide incident
rates was seen with VRE, shifting from 34 to 15 infections within
the PX-UV disinfection period (P = .070).
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In the ICU alone, all 3 infection types similarly experienced sig-
niﬁcant reductions (P = .01) together. However, changes in VRE
incidence was only statistically signiﬁcant alone (P = .01). None-
theless, C diﬃcile, MRSA, and VRE rates decreased by 45%, 56%, and
87%, respectively.
On all other non-ICU ﬂoors combined, only a 40% change in C
diﬃcile infections alone was relevant (P = .04). MRSA infection rates
actually increased 52% (P = .05) in this setting, unlike the 56% de-
crease observed within the ICU alone (P = .22). In addition, VRE
acquisition rates actually decreased 37%, despite the focus of only
C diﬃcile terminal cleans being disinfected with full-spectrum ul-
traviolet light in the non-ICU setting.
DISCUSSION
Implementation of PX-UV disinfection resulted in a 29% and 61%
decrease in facility-wide and ICU-wide infections, respectively, for
all 3 pathogens together. These ﬁndings are encouraging given the
history of environmental implicated infections and exceptional en-
vironmental reservoirs associated with these organisms.25 The
difference in infection rates for the ICU compared with the non-
ICU areas demonstrates the increased risk of infection in the ICU
and the leverage that ICU-based interventions can have on the
facility-wide rates. Furthermore, there seems to be a direct corre-
lation between the focused use of PX-UV on all C diﬃcile discharges
facility-wide and a decrease in postincidence infection rates. Only
C diﬃcile infections were signiﬁcantly reduced facility-wide, and only
C diﬃcile contact precaution rooms received enhanced disinfec-
tion in the non-ICU setting.
A novel aspect of this study is that it examines 2 different de-
ployment strategies for ultraviolet disinfection: using ultraviolet
disinfection for every terminal discharge on a unit and for C diﬃcile
isolation rooms only. The different magnitude of rate reduction as-
sociated with these 2 deployment strategies indicates best practices
for ultraviolet disinfection. This is an advantage over studies that
examine the disinfection eﬃcacy only because those studies do not
give information about where ultraviolet disinfection should be de-
ployed to impact infection rates.
Diagnostics remained consistent over the time period as the
facility adopted polymerase chain reaction technology for C diﬃcile
diagnosis in January 2011. Additionally, a ventialator associated
pneumonia prevention bundle was initiated in the ICUs in 2007.
An antimicrobial stewardship program was initiated in January
2012 (11 months before the ultraviolet device was introduced)
and resulted in reductions in the use of ciproﬂoxacin and
moxiﬂoxacin (by 73% and 81%, respectively); however, this change
was not linked to a reduction of the nosocomial C diﬃcile
rate prior to the introduction of the ultraviolet device. These pro-
grams were active and monitored throughout the intervention
period.
It is encouraging to identify a consistent downward trend in
infections of each organism type alone within the ICU, where usage
goals were centered on ultraviolet exposure after every discharge.
This change was not as signiﬁcant in the non-ICU setting, where
only C diﬃcile contact precaution rooms were exposed to
the ultraviolet disinfection cycles. This observation supports the
consistent feasibility of PX-UV in an area of higher acuity and patient
ﬂow.
Table 1
Comparison of infection rates [(incidence/patient days) × 1,000] for common MDROs before and after implementation of PX-UV: comparison of non-ICU rates pre and post
PX-UV disinfection
Facility Organism Pre rate Post rate % Change P value Pre incidence Post incidence Pre patient days Post patient days
SSH Clostridium diﬃcile 0.75 0.45 −40 .04 71 38 94,777 84,161
SSH MRSA 0.24 0.37 52 .05 23 31 94,777 84,161
SSH VRE 0.26 0.17 −37 .27 25 14 94,777 84,161
SSH All 3 1.26 0.99 −21 .16 119 83 94,777 84,161
NOTE. A signiﬁcant difference exists when P < .05.
Abbreviations: ICU, intensive care unit; MDRO, multidrug-resistant organisms; MRSA, methicillin-resistant Staphylococcus aureus; pre, January 2011-October 2012; post, No-
vember 2012-August 2014; PX-UV, pulsed xenon ultraviolet; SSH, South Seminole Hospital; VRE, vancomycin-resistant Enterococci.
Table 2
Comparison of infection rates [(incidence/patient days) × 1,000] for common MDROs before and after implementation of PX-UV: comparison of ICU rates pre and post PX-
UV disinfection
Facility Organism Pre rate Post rate % Change P value Pre incidence Post incidence Pre patient days Post patient days
SSH Clostridium diﬃcile 2.40 1.31 −45 .25 11 5 4,579 3,805
SSH MRSA 2.40 1.05 −56 .22 11 4 4,579 3,805
SSH VRE 1.97 0.26 −87 .01 9 1 4,579 3,805
SSH All 3 6.77 2.63 −61 .01 31 10 4,579 3,805
NOTE. A signiﬁcant difference exists when P < .05.
Abbreviations: ICU, intensive care unit; MDRO, multidrug-resistant organisms; MRSA, methicillin-resistant Staphylococcus aureus; pre, January 2011-October 2012; post, No-
vember 2012-August 2014; PX-UV, pulsed xenon ultraviolet; SSH, South Seminole Hospital; VRE, vancomycin-resistant Enterococci.
Table 3
Comparison of infection rates [(incidence/patient days) × 1,000] for common MDROs before and after implementation of PX-UV: comparison of facility rates pre and post
PX-UV disinfection
Facility Organism Pre rate Post rate % Change P value Pre incidence Post incidence Pre patient days Post patient days
SSH Clostridium diﬃcile 0.83 0.49 −41 .01 82 43 99,356 87,966
SSH MRSA 0.34 0.41 20 .23 34 36 99,356 87,966
SSH VRE 0.34 0.17 −50 .07 34 15 99,356 87,966
SSH All 3 1.51 1.07 −29 .01 150 94 99,356 87,966
NOTE. A signiﬁcant difference exists when P < .05.
Abbreviations: ICU, intensive care unit; MDRO, multidrug-resistant organisms; MRSA, methicillin-resistant Staphylococcus aureus; pre, January 2011-October 2012; post, No-
vember 2012-August 2014; PX-UV, pulsed xenon ultraviolet; SSH, South Seminole Hospital; VRE, vancomycin-resistant Enterococci.
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South Seminole Hospital experienced 39 fewer C diﬃcile
and 19 fewer VRE infections within the 22-month facility-wide
PX-UV intervention window. In addition, >280 and 110
patient bed days were generated for each infection, respectively.
Assuming a similar trend in infection rates without the
intervention in place, this could have potentially resulted in net
savings of >$730,000. C diﬃcile and VRE cases are nonreimburs-
able, costing a facility an additional average $14,000 per
case.26,27
These outcomes suggest that enhanced environmental disinfec-
tion plays a signiﬁcant role in the risk mitigation of HAIs. Using
prior room occupancy risk as a proxy measure, previous literature
has suggested prior risk for MRSA, C diﬃcile, and VRE to be 40%,28,29
135%,14 and 280%,30 respectively, on the new admission of a
patient; however, these rate estimates may not apply to
all settings, such as community hospitals. The ICU at South
Seminole Hospital had no recorded infections for any organism
between May and December 2013, and alone only 1 VRE
incident has been recorded on addition of the PX-UV interven-
tion, with zero infections occurring between November 2012 and
July 2014. It has been suggested that enhanced environmental clean-
ing could have a larger impact on VRE because the environment
could play a larger role in transmission.31 However, slight varia-
tion between absolute changes in infection rates between organisms
is most likely attributed to a combination of a small patient day
population and the fact that HAIs are a rare event statistic in this
analysis.
Although insigniﬁcant, VRE incidence rates decreased by ap-
proximately 40% in non-ICU areas. This is surprising, given PX-UV
was not deployed in VRE contact precaution situations and MRSA
infections were actually trending upward of >50% within the in-
tervention. It is possible that the ICU is the primary transmission
point of VRE at South Seminole Hospital, causing all other step-
down areas of patient care within the facility to be effected by the
drastic reduction of VRE rates within the ICU. However, these trends
might be irrelevant, given these exceedingly insigniﬁcant statisti-
cal conclusions.
Limitations of this study include using historical comparison data
rather than an experimental design, effecting potential statistical-
ly signiﬁcant conclusions within the area of the ICU. Because of the
nature of the study design, confounders, such as hand hygiene com-
pliance, manual environmental cleaning quality, antimicrobial
stewardship, and colonization pressure, were not controlled and
could have inﬂuenced the outcome. In general, a small patient pop-
ulation provides less sensitivity in detecting signiﬁcant changes. For
ICU patient days to match the absolute effect size of the rest of the
hospital, our intervention period would have required an excep-
tional length of time.
CONCLUSIONS
Signiﬁcant infection reduction trends in cases where all 3 or-
ganisms are paired together suggest a signiﬁcant overall impact of
PX-UV on patient outcomes and a signiﬁcant net return on invest-
ment. As more evidence unfolds within the literature, the
environmental signiﬁcance to nosocomial infection acquisition and
potential for no-touch disinfection can be better justiﬁed and
compared.
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